2008: Late Breaking Posters
Search
or
Browse by Day
Late Breaking Posters
Monday, October 27, 2008
L1
Efficacy and Safety of Canakinumab (ACZ885), a Fully Human Anti-interleukin-1β Antibody, in Cryopyrin Associated Periodic Fever Syndrome: Results of a Multicenter, Randomized, Double-blind, Phase III Study
L2
Transdermal Delivery Of hPTH (1-34) (zp-pth) is Effective in Increasing Bone Mineral Density of the Lumbar Spine and Hip in Postmenopausal Women with Osteoporosis
L3
Early Effects of Denosumab in Postmenopausal Women With Low Bone Mineral Density Previously Treated with Alendronate
L4
Stopping TNF-blockade Therapy in Early RA: Predictors of Sustained Remission
L5
From No Increase to Doubled Risk After Ten Years: Morbidity and Mortality from Myocardial Infarction in Newly Diagnosed Rheumatoid Arthritis
L6
Type 1 Interferon Pathway Activation Predicts Flares of Disease Activity in SLE
L7
Beneficial Relationship of Serum Urate (sUA) Reduction and Estimated Glomerular Filtration Rate (eGFR) Improvement/Maintenance in Hyperuricemic Gout Subjects Treated for up to 5.5 Years with Febuxostat (FEB)
L8
Limited Efficacy of Glucocorticoids in Very Early Arthritis - Results of the Stop Arthritis Very Early (SAVE) Trial, an International Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial
L9
Treatment of Osteoarthritis (OA) With Continuous vs Intermittent Celecoxib
L10
Long-circulating Liposomal Prednisolone versus Pulse Intramuscular Methylprednisolone in Patients with Active Rheumatoid Arthritis
See more of:
Late Breaking Abstract Poster Sessions
<< Previous Session Level
|
Next Session Level >>